Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01258790 · ClinicalTrials.gov registry record · NA

Repetitive Transcranial Magnetic Stimulation to Reduce Tics

A NA study of Tourette Syndrome, sponsored by Children's Hospital Medical Center, Cincinnati.

Completed
Registry status
NA
Development phase
12
Enrollment target
1
Study location

NCT01258790 is a NA study of Tourette Syndrome that has completed, run by Children's Hospital Medical Center, Cincinnati. The registered enrollment target is 12 participants, below the 86-participant average among 33 other Tourette Syndrome trials with a reported enrollment target (86% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01258790, a NA study of Tourette Syndrome, has completed, sponsored by Children's Hospital Medical Center, Cincinnati.

COMPLETED
Registry status
NA
Development phase
12 participants
Enrollment target
1
Study location

Study Summary

Specific Aim1: Using a paradigm of Transcranial Magnetic Stimulation called Continuous Theta Burst Stimulation (cTBS) to reduce tics in Tourette Syndrome subjects Hypothesis1: cTBS, compared to sham stimulation, will reduce tic severity by at least 25% as measured by the Yale Global Tic Severity Scale Specific Aim2: Using cTBS to further understand neural correlates of tic generation Hypothesis2: Functional MRI BOLD signal activation pattern will change after cTBS and this change will correlate with clinical improvement in tic severity

Conditions Studied

Interventions

  • DEVICE Sham Repetitive Transcranial Magnetic Stimulation
  • DEVICE Active Repetitive Transcranial Magnetic Stimulation

Study Locations (1)

Ohio

  • Cincinnati Children's Medical Center - Cincinnati

Trial Details

FieldValue
Enrollment Target 12 participants
Start Date 2010-11
Est. Completion 2013-03
Phase NA

What the Registry Record Tells You About NCT01258790

The ClinicalTrials.gov registry entry for NCT01258790 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 86-participant average among 33 other Tourette Syndrome trials with a reported enrollment target (86% lower). The listed sponsor is Children's Hospital Medical Center, Cincinnati, which has 571 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Tourette Syndrome appearing as the primary indexed condition, and to 2 interventions - of which Sham Repetitive Transcranial Magnetic Stimulation is the first listed.

NCT01258790 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.

Frequently Asked Questions

What is clinical trial NCT01258790 about?

NCT01258790 is a clinical study titled "Repetitive Transcranial Magnetic Stimulation to Reduce Tics". Specific Aim1: Using a paradigm of Transcranial Magnetic Stimulation called Continuous Theta Burst Stimulation (cTBS) to reduce tics in Tourette Syndrome subjects Hypothesis1: cTBS, compared to sham stimulation, will reduce tic severity by at least 25% as measured by the Yale Global Tic Severity Sc...

What is the current status of trial NCT01258790?

This trial is currently completed. It is a NA study. The enrollment target is 12 participants. The study started on 2010-11. Estimated completion is 2013-03.

What conditions does trial NCT01258790 study?

This clinical trial studies the following conditions: Tourette Syndrome.

What interventions are being tested in trial NCT01258790?

The interventions under investigation include: Sham Repetitive Transcranial Magnetic Stimulation (DEVICE), Active Repetitive Transcranial Magnetic Stimulation (DEVICE).

Who is sponsoring clinical trial NCT01258790?

This trial is sponsored by Children's Hospital Medical Center, Cincinnati, which has 571 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01258790 being conducted?

This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Tourette Syndrome

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.